4//SEC Filing
Owens Daniel E. 4
Accession 0001209191-22-059532
CIK 0001630627other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 9:00 PM ET
Size
14.6 KB
Accession
0001209191-22-059532
Insider Transaction Report
Form 4
Owens Daniel E.
Chief HR Officer
Transactions
- Exercise/Conversion
Common Stock
2022-12-02$7.03/sh+3,750$26,355→ 14,450 total - Sale
Common Stock
2022-12-02$25.00/sh−3,750$93,750→ 10,700 total - Exercise/Conversion
Common Stock
2022-12-02$17.00/sh+1,875$31,875→ 12,575 total - Sale
Common Stock
2022-12-02$25.00/sh−1,875$46,875→ 10,700 total - Exercise/Conversion
Stock Option Right to Buy
2022-12-02−3,750→ 182,625 totalExercise: $7.03Exp: 2031-02-02→ Common Stock (3,750 underlying) - Exercise/Conversion
Stock Option Right to Buy
2022-12-02−1,875→ 71,688 totalExercise: $17.00Exp: 2031-04-22→ Common stock (1,875 underlying)
Footnotes (4)
- [F1]The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Includes 6,700 RSUs.
- [F3]The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.
- [F4]The stock option vests in equal annual installments over 4 years, commencing on April 22, 2022, with the last installment on April 22, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.
Documents
Issuer
TREACE MEDICAL CONCEPTS, INC.
CIK 0001630627
Entity typeother
Related Parties
1- filerCIK 0001858105
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 9:00 PM ET
- Size
- 14.6 KB